Search - tctmd.com

Displaying 881 - 900 of 1291

Sort: Relevancy | Date

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

News Industry News

CryoLife Receives Expanded Indication for BioGlue® in Japan

July 09, 2015

News Industry News

FDA ruling allows heart valve patients to limit blood-thinning medication

July 08, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

Presentation

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Presenter: Michael J. Reardon

July 06, 2015

News Daily News

Poor Mobility Strongly Predicts Mortality in TAVR Patients

Yael L. Maxwell

July 06, 2015

News Industry News

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

July 02, 2015

News Industry News

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

June 24, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Industry News

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

June 23, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Advertisement

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

CryoLife Receives Expanded Indication for BioGlue® in Japan

FDA ruling allows heart valve patients to limit blood-thinning medication

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Poor Mobility Strongly Predicts Mortality in TAVR Patients

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content